Harats D - Search Results

1

Intolerance to statins: mechanisms and management.

Bitzur R, Cohen H, Kamari Y, Harats D. Bitzur R, et al. Among authors: harats d. Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S325-30. doi: 10.2337/dcS13-2038. Diabetes Care. 2013. PMID: 23882066 Free PMC article. Review. No abstract available.

2

Suppression of atherogenesis in female low-density lipoprotein receptor knockout mice following magnesium fortification of drinking water: the importance of diet.

Sherer Y, Shoenfeld Y, Shaish A, Levkovitz H, Bitzur R, Harats D. Sherer Y, et al. Among authors: harats d. Pathobiology. 2000 Mar-Apr;68(2):93-8. doi: 10.1159/000028119. Pathobiology. 2000. PMID: 10878506

3

The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice.

Sharabi Y, Grossman E, Sherer Y, Shaish A, Levkovitz H, Bitzur R, Harats D. Sharabi Y, et al. Among authors: harats d. Pathobiology. 2000;68(6):270-4. doi: 10.1159/000055937. Pathobiology. 2000. PMID: 11493760

4

Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model.

Sherer Y, Bitzur R, Cohen H, Shaish A, Varon D, Shoenfeld Y, Harats D. Sherer Y, et al. Among authors: harats d. Magnes Res. 2001 Sep;14(3):173-9. Magnes Res. 2001. PMID: 11599549

5

Association between serum apolipoprotein C(II) concentration and coronary heart disease.

Gerber Y, Goldbourt U, Cohen H, Harats D. Gerber Y, et al. Among authors: harats d. Prev Med. 2002 Jul;35(1):42-7. doi: 10.1006/pmed.2002.1045. Prev Med. 2002. PMID: 12079439

6

Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model.

Levi Z, Shaish A, Yacov N, Levkovitz H, Trestman S, Gerber Y, Cohen H, Dvir A, Rhachmani R, Ravid M, Harats D. Levi Z, et al. Among authors: harats d. Diabetes Obes Metab. 2003 Jan;5(1):45-50. doi: 10.1046/j.1463-1326.2003.00240.x. Diabetes Obes Metab. 2003. PMID: 12542724

7

Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water.

Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R, Harats D. Cohen H, et al. Among authors: harats d. Biol Trace Elem Res. 2002 Winter;90(1-3):251-9. doi: 10.1385/BTER:90:1-3:251. Biol Trace Elem Res. 2002. PMID: 12666839

8

Omapatrilat, an angiotensin-converting enzyme and neutral endopeptidase inhibitor, attenuates early atherosclerosis in diabetic and in nondiabetic low-density lipoprotein receptor-deficient mice.

Levy Z, Dvir A, Shaish A, Trestman S, Cohen H, Levkovietz H, Rhachmani R, Ravid M, Harats D. Levy Z, et al. Among authors: harats d. Int J Exp Diabesity Res. 2003 Jan-Mar;4(1):59-64. doi: 10.1080/15438600303728. Int J Exp Diabesity Res. 2003. PMID: 12745671 Free PMC article.

9

[Guidelines for the prevention and treatment of atherosclerosis and cardiovasculer diseases: general recommendations--hypertension].

Bitzur R, Harats D, Rubinstein A; Society of Detection, Prevention and treatment of Atherosclerosis;. Bitzur R, et al. Among authors: harats d. Harefuah. 2005 Jul;144(7):506-12, 525. Harefuah. 2005. PMID: 16082905 Hebrew.

10

Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter.

Harats D, Ben-Shushan D, Cohen H, Gonen A, Barshack I, Goldberg I, Greenberger S, Hodish I, Harari A, Varda-Bloom N, Levanon K, Grossman E, Chaitidis P, Kühn H, Shaish A. Harats D, et al. Cancer Lett. 2005 Nov 8;229(1):127-34. doi: 10.1016/j.canlet.2005.02.017. Cancer Lett. 2005. PMID: 16157225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page